Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Rockwell Medical (RMTI) Shares Outstanding (2016 - 2026)

Rockwell Medical filings provide 16 years of Shares Outstanding readings, the most recent being $39.4 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 15.7% to $39.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $39.4 million, a 15.7% increase, with the full-year FY2025 number at $39.4 million, up 15.7% from a year prior.
  • Shares Outstanding hit $39.4 million in Q4 2025 for Rockwell Medical, roughly flat from $39.4 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $39.4 million in Q4 2025 to a low of $8.5 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $22.6 million (2023), compared with a mean of $21.8 million.
  • Biggest five-year swings in Shares Outstanding: tumbled 90.87% in 2021 and later surged 155.45% in 2023.
  • Rockwell Medical's Shares Outstanding stood at $8.5 million in 2021, then soared by 42.36% to $12.2 million in 2022, then soared by 139.49% to $29.1 million in 2023, then grew by 16.91% to $34.1 million in 2024, then increased by 15.7% to $39.4 million in 2025.
  • The last three reported values for Shares Outstanding were $39.4 million (Q4 2025), $39.4 million (Q3 2025), and $34.4 million (Q2 2025) per Business Quant data.